We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+2.7%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$746M
AUM Growth
-$106M
Cap. Flow
+$120M
Cap. Flow %
16.15%
Top 10 Hldgs %
44.28%
Holding
510
New
122
Increased
34
Reduced
58
Closed
238

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$49.5M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$21.8M
3
DIS icon
Walt Disney
DIS
+$16.1M
4
MSFT icon
Microsoft
MSFT
+$11M
5
TSM icon
TSMC
TSM
+$8.27M

Top Sells

Rank Stock Value
1
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$6.55M
2
BHC icon
Bausch Health
BHC
+$5.35M
3
DLR icon
Digital Realty Trust
DLR
+$1.95M
4
PFSI icon
PennyMac Financial
PFSI
+$1.67M
5
COP icon
ConocoPhillips
COP
+$1.62M

Sector Composition

Rank Sector Weight
1 Miscellaneous 79.32%
2 Consumer Discretionary 7.31%
3 Communication Services 4.95%
4 Technology 3.75%
5 Energy 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALT icon
176
CALL
Altimmune
ALT
$642M
$298K 0.04%
+23,300
New +$344K
NTLA icon
177
CALL
Intellia Therapeutics
NTLA
$1.66B
$280K 0.04%
5,000
-15,700
-76% -$974K
UVE icon
178
Universal Insurance Holdings
UVE
$1.23B
$274K 0.04%
+27,804
New +$333K
BHC icon
179
CALL
Bausch Health
BHC
$2.21B
$270K 0.04%
39,200
-196,000
-83% -$1.36M
ENVX icon
180
CALL
Enovix
ENVX
$663M
$268K 0.04%
+16,686
New +$246K
AKRO
181
CALL
DELISTED
Akero Therapeutics
AKRO
$262K 0.04%
+7,700
New +$118K
AKRO
182
PUT
DELISTED
Akero Therapeutics
AKRO
$262K 0.04%
+7,700
New +$118K
ADT icon
183
ADT
ADT
$5.17B
$262K 0.04%
35,000
+10,000
+40% +$75.4K
RARE icon
184
CALL
Ultragenyx Pharmaceutical
RARE
$1.34B
$261K 0.04%
+6,300
New +$324K
BCS icon
185
CALL
Barclays
BCS
$86.7B
$256K 0.03%
40,000
-1,300
-3% -$10K
PLAY icon
186
CALL
Dave & Buster's
PLAY
$295M
$254K 0.03%
8,200
-50,000
-86% -$1.87M
AMPH icon
187
Amphastar Pharmaceuticals
AMPH
$1.01B
$249K 0.03%
+8,878
New +$290K
LNG icon
188
Cheniere Energy
LNG
$56.6B
$249K 0.03%
+1,500
New +$228K
CP icon
189
CALL
Canadian Pacific Kansas City
CP
$78.4B
$247K 0.03%
+3,700
New +$279K
SHW icon
190
CALL
Sherwin-Williams
SHW
$78.5B
$246K 0.03%
+1,200
New +$284K
GOSS icon
191
CALL
Gossamer Bio
GOSS
$65.6M
$246K 0.03%
256
+193
+306% +$192K
SGMO
192
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$245K 0.03%
+50,000
New +$257K
NOAH
193
Noah Holdings
NOAH
$559M
$242K 0.03%
+18,335
New +$312K
ALGN icon
194
CALL
Align Technology
ALGN
$10.7B
$228K 0.03%
+1,100
New +$283K
ADP icon
195
Automatic Data Processing
ADP
$110B
$226K 0.03%
+1,000
New +$236K
SIGA icon
196
PUT
SIGA Technologies
SIGA
$218M
$222K 0.03%
+21,600
New +$347K
LBAI
197
DELISTED
Lakeland Bancorp Inc
LBAI
$210K 0.03%
13,087
+2,087
+19% +$33.2K
ORKA
198
PUT
Oruka Therapeutics
ORKA
$6.12B
$206K 0.03%
8,333
– –
SNAP icon
199
PUT
Snap
SNAP
$9.88B
$201K 0.03%
20,500
+5,000
+32% +$58.2K
RCL icon
200
CALL
Royal Caribbean
RCL
$69.6B
$197K 0.03%
5,200
– –
6 7
8
9 10

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q3 2022 Portfolio in Review

As of Q3 2022, SG3 Management held 510 positions worth $746M, down 12% from $852M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

SG3 Management deployed $120M of net new capital in Q3 2022, opening 122 new positions and adding to 34 existing holdings. Its largest new stake was Tesla: 177,200 shares worth $47M.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 95% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was LivaNova, an estimated $1.29M trimmed.

  • SG3 Management's largest Q3 2022 buy was Tesla: 177,200 shares worth $47M.
  • SG3 Management added most to Apellis Pharmaceuticals in Q3 2022, an estimated $2.3M increase.
  • SG3 Management's biggest Q3 2022 reduction was LivaNova, cutting an estimated $1.29M.
  • SG3 Management fully exited KraneShares CSI China Internet ETF in Q3 2022, selling an estimated $6.55M.
  • SG3 Management's ten largest holdings make up 44% of its $746M portfolio in Q3 2022.
  • SG3 Management opened 122 new positions and closed 238 in Q3 2022.
  • SG3 Management's portfolio value fell 12% quarter-over-quarter to $746M.

Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.